KRMD KORU Medical Systems, Inc.

Nasdaq korumedical.com


$ 4.04 $ 0.03 (0.75 %)    

Friday, 17-Oct-2025 15:59:50 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 4.05
$ 3.98
$ 3.82 x 25
$ 4.48 x 90
$ 3.92 - $ 4.15
$ 1.86 - $ 5.05
83,070
na
187.25M
$ 0.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 03-12-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 03-13-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-08-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-03-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 03-02-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-23-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 03-04-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 03-05-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-06-2018 06-30-2018 10-Q
30 05-07-2018 03-31-2018 10-Q
31 11-03-2017 09-30-2017 10-Q
32 08-04-2017 06-30-2017 10-Q
33 05-05-2017 02-28-2017 10-K
34 01-05-2017 11-30-2016 10-Q
35 10-07-2016 08-31-2016 10-Q
36 06-30-2016 05-31-2016 10-Q
37 05-13-2016 02-29-2016 10-K
38 01-08-2016 11-30-2015 10-Q
39 10-02-2015 08-31-2015 10-Q
40 07-10-2015 05-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 forcast-orthopedics-and-koru-medical-systems-enters-partnership-to-incorporate-korus-freedomedge-infusion-system-into-forcasts-platform-for-treating-periprosthetic-joint-infection

ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. (NASDAQ: KRMD) today jointly announced an agreement leveraging KORU Me...

 cirtec-medical-appoints-shar-matin-as-ceo-effective-september-2-2025

Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precisio...

 koru-medical-systems-raises-fy2025-sales-guidance-from-38500m-39500m-to-39500m-40500m-vs-38978m-est

KORU Medical Systems (NASDAQ:KRMD) raises FY2025 sales outlook from $38.500 million-$39.500 million to $39.500 million-$40.500 ...

 koru-medical-systems-q2-adj-eps-001-beats-002-estimate-sales-10195m-beat-9460m-estimate

KORU Medical Systems (NASDAQ:KRMD) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of ...

 piper-sandler-maintains-neutral-on-koru-medical-systems-lowers-price-target-to-35

Piper Sandler analyst Jason Bednar maintains KORU Medical Systems (NASDAQ:KRMD) with a Neutral and lowers the price target f...

 koru-medical-systems-raises-fy2025-sales-guidance-from-3800m-3900m-to-3850m-3950m-vs-3843m-est

KORU Medical Systems (NASDAQ:KRMD) raises FY2025 sales outlook from $38.00 million-$39.00 million to $38.50 million-$39.50 mill...

 koru-medical-systems-q1-sales-963m-beat-887m-estimate

KORU Medical Systems (NASDAQ:KRMD) reported quarterly sales of $9.63 million which beat the analyst consensus estimate of $8.87...

 piper-sandler-downgrades-koru-medical-systems-to-neutral-maintains-price-target-to-45

Piper Sandler analyst Jason Bednar downgrades KORU Medical Systems (NASDAQ:KRMD) from Overweight to Neutral and maintains th...

 koru-medical-signs-agreement-for-next-gen-subcutaneous-infusion-system-with-global-pharmaceutical-company-co-collaborates-with-schott-pharma

KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology compan...

 koru-medical-announces-collaboration-with-a-global-pharmaceutical-manufacturer-for-phase-iii-trial-on-renal-disorder-targeting-30k-patients-with-300k-annual-infusions-focusing-on-drug-safety-efficacy-and-performance-for-kidney-transplant-complications

KORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focu...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION